Press Release

CD BIOSCIENCES LAUNCHES HYPERSPECTRAL IMAGING TECHNOLOGY FOR FOOD SAFETY



CD BioSciences has recently announced the launch of the Hyperspectral Imaging Technology to assist researchers in the detection of biological contaminants of food production at different stages.

FOR IMMEDIATE RELEASE

29/03/2023

CD BioSciences, a US-based biotechnology company focusing on the development of imaging technology, has recently announced the launch of the Hyperspectral Imaging Technology to assist researchers in the detection of biological contaminants of food production at different stages, including pathogenic microorganisms and spoilage microorganisms.

Hyperspectral imaging, also known as chemical imaging or spectral imaging, is an emerging technology that combines traditional imaging with spectroscopy to acquire and analyze a large amount of spectral and spatial information from real scenes in the form of three-dimensional images. Compared with traditional imaging and spectroscopy, image processing and analysis are the core of hyperspectral imaging technology. This technology is increasingly used in food safety inspection and quality control due to its ability to provide detailed information about the composition and properties of various food products.

Each food product has a unique spectral signature due to its chemical composition and physical structure, as well as the way of reflecting, scattering or absorbing energy when exposed to electromagnetic radiation of different wavelengths. Among the increasing number of food contaminants, foodborne microorganisms can cause structural and chemical changes within a short period of time. These changes can be detected based on the intensity of scattering or absorption of the incident radiation, thus determining the presence of contaminants and their spatial distributions within food samples.

Hyperspectral imaging technology is a non-destructive analysis technology with high accuracy, reliability, and performance. It is used to detect biological pollutants for food production, such as pathogenic and spoilage microorganisms. CD BioSciences can use hyperspectral imaging technology to provide customers with a series of food microbiological testing services to ensure the quality and safety of food, including the detection of living microorganisms in fruit, vegetable, cereal, and detection of microbial contamination in beef, pork, chicken, fish, and egg.

CD BioSciences possesses a professional team with extensive working experience in the imaging field. Its team can provide customers with personalized imaging services that meet research needs in the fields of biology, microbiology, medicine, and food. In addition to food microbiological testing services, CD BioSciences can also offer customized services for tissue imaging and analysis, cell imaging analysis, molecular imaging analysis, microorganisms imaging analysis, and imaging analysis for drug discovery & development.

For customers interested in learning more about Hyperspectral Imaging Technology, please visit CD BioSciences at https://www.bioimagingtech.com.

About CD BioSciences

CD BioSciences is a biotechnology company committed to the development of imaging technology for many years. Its scientists can utilize high-content imaging, nanoparticle imaging, imaging flow cytometry, time-lapse imaging, and other techniques to manifest cell structure, cell migration, cell proliferation, pathogen infection mechanisms, and interactions between protein molecules. In addition, the team is capable of applying powerful analytical software to capture images of cellular structure, subcellular, or tissues to obtain useful information.

Tags:
Hyperspectral Imaging Technology  |  CD BioSciences  |  

---

Organisation Profile:
CD BioSciences is a trusted research product supplier and CRO based in New York. With high-quality reagents and comprehensive services, CD BioSciences is the one-stop shop devoted to researchers making advancements in signaling pathway studies.






Press release contact details for CD BioSciences

NameCD BioSciences
Tel
Fax
Email
Websitehttps://www.cd-biosciences.com/
OrganisationCD BioSciences
Address
Town
County
Postcode




Other press releases from CD BioSciences

CD BioSciences Introduces New Solutions to Support Cell Death Studies
CD BioSciences Launches Scaffold-Based Technologies for 3D Cell Culture
CD BioSciences Launches Hyperspectral Imaging Technology for Food Safety
CD BioSciences Introduces New Cell Death Solutions to Facilitate Research
CD BioSciences Launches Fluorescence Correlation Spectroscopy
CD BioSciences Introduces Various Solutions for Studying Apoptotic Cell Death
CD BioSciences Launches Nanoparticles Imaging Technology for Scientists
CD BioSciences Introduces Multiple Solutions for Type II Cell Death Research
CD BioSciences Launches New Time-Lapse Imaging Services for Scientists
CD BioSciences Launches New Solutions for Microautophagy Research
CD BioSciences Announces New Immunofluorescence-Based Services
CD BioSciences Launches New Solutions for Type III Cell Death Research
CD BioSciences Launches New Super-Resolution Imaging Technology for Biomedical Research
CD BioSciences Announces New Research Solutions on Mitotic Catastrophe
CD BioSciences Announces New Single Molecule Fluorescence Imaging Technology
CD BioSciences Introduces New Metabolic Homeostasis Research Solutions
CD BioSciences Launches New Services to Study Catabolism in Diabetes
CD BioSciences Launches New 3D Tissue Imaging Services
HighRun DataScience Launches Data Science Platform for Global Customers
CD BioSciences Announces New Solutions for Studying Anabolism
CD Biosciences Introduces 3D Image Analysis Services For Bioimaging Research
CD BioSciences Expands Portfolio with Wide Range of Embedding Resins and Kits for Electron and Light Microscopy
CD BioSciences Announces New Solutions for Glucose Homeostasis Research
CD Biosciences Announces Expanded Capabilities for Mechanistic Target of Rapamycin Research in Diabetes and Metabolism
CD Biosciences Launches Substrate-Chromogens for Immunohistochemistry
CD BioSciences Launches New Range of In Vivo Imaging Reagents for Scientific Research
CD BioSciences Introduces IHC Ancillaries for Enhanced Research and Diagnostics
CD BioSciences Announces Comprehensive Range of Nervous System Tissue Microarrays

Disclaimer:
Issuers of the press releases are solely responsible for the content of their press releases. Connect2business.co.uk cannot be held liable for the content posted by others to this website.